One of the latest treatment for the hepatitis C virus as of June 2014 is a drug called Harvoni, which is taken via oral administration on a daily basis. The drug is a combination of two antiviral medications sofusbuvir and ledipasvir. Other treatment for the disease also involves combining two drugs: pegylated interferon and rivabirin, which are taken during the course of 24 to 48 weeks.
Hepatitis C is a type of viral infection that primarily affects the liver. Some of those infected by the hepatitis C virus often experience little to no symptoms at all. However, if left unchecked and untreated, hepatitis C infection can lead to even more serious liver diseases including cirrhosis. cancer of the liver, liver failure, esophageal and gastric varices. Hepatitis C is among the five known types of the disease with the other types being A, B, D and E.
Treatment with the combination of the drugs pegylated interferon and ribavirin used to be the most common treatment for hepatitis C. The interferon is administered via injection and the rivabirin is to be taken orally in the form of a tablet or a drug. Treatment with this combination is known to have an 85 percent success rate.
Surgery is also one of the treatment options for hepatitis C and in some cases, the disease is one of the usual reasons for liver transplant procedures. However, the disease is known to recur in liver transplant patients. Among those who are most at risk of contracting hepatitis C include those who underwent blood transfusions and organ transplant procedures, or are recreational drug users.